Daniela Proietti

Author PubWeight™ 10.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Beta-glucan-CRM197 conjugates as candidates antifungal vaccines. Vaccine 2010 1.09
2 Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases. Vaccine 2008 0.94
3 Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc Natl Acad Sci U S A 2013 0.91
4 Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide. ACS Chem Biol 2012 0.86
5 Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate. Vaccine 2010 0.84
6 Synthesis of Staphylococcus aureus type 5 capsular polysaccharide repeating unit using novel L-FucNAc and D-FucNAc synthons and immunochemical evaluation. Bioorg Med Chem 2012 0.84
7 Preparation, characterization and immunogenicity of HIV-1 related high-mannose oligosaccharides-CRM197 glycoconjugates. Glycoconj J 2010 0.84
8 Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development. Glycobiology 2013 0.80
9 Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135. Vaccine 2005 0.80
10 First synthesis of C. difficile PS-II cell wall polysaccharide repeating unit. Org Lett 2010 0.79
11 Tyrosine-directed conjugation of large glycans to proteins via copper-free click chemistry. Bioconjug Chem 2014 0.79
12 Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping. Chembiochem 2014 0.79
13 Isolation of oligosaccharides from a partial-acid hydrolysate of pneumococcal type 3 polysaccharide for use in conjugate vaccines. Carbohydr Res 2002 0.77